ThetaBiomarkers is one of the supported startups in the first S3E Charge Accelerator Programme.
ThetaBiomarkers have created an innovative and technologically advanced clinical laboratory for the provision of quality metabolomics-based services for health and wellness, ensuring that final users get accurate treatment decisions. They are a deep-tech company that offers simultaneous analysis for a plethora of biomarkers and drugs, using state-of-the-art instrumentation, bespoke algorithms and sophisticated software. They offer evidence-based solutions, tailored to the needs of our customers, in order to provide a personalized metabolism tracker and personalized reports and wellness/health advice.
Also, they have developed convenient, safe and alternative to in-clinic visits testing options for different body fluids. They launched a new, innovative technology product for quick and easy sampling outside the clinical laboratory, avoiding costly cold chain transfers. The ability to sample and ship small volumes of liquid biosamples on a simple card enables uninterrupted monitoring of vulnerable or remote-located patients, especially in the post COVID-19 pandemic era.
They are at the spearhead of technology development generating new bioanalytical approaches, promoting application to numerous sectors and activities. Their scalable and customisable portfolio delivers unique added-value to researchers and healthcare providers to in-market wellbeing management.
Learn more about ThetaBiomarkers by watching the pitch done by their CEO, Olga Begou, during the Charge Open Day on 6th July 2023.
Would you like to get in touch with them? Let us know! Email us at info@south3e.eu